BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Emerging Biotech

Vazyme Signs Global Strategic Cooperation Agreement with Azenta

Dr. Nie Junwei, General Manager of Life Science Division, Vazyme, and Mr. George Ge, General Manager of Azenta China, witnessed by Dr. Cao Lin, C...

June 01, 2023 | News

Luzhu Biotechnology's LZ901 Completes Phase II Clinical Trial for Herpes Zoster Vaccine

Beijing Luzhu Biotechnology Co., Ltd. ("Luzhu Biotechnology" or the "Company", together with its subsidiaries, the "Group", stock code: 02480.HK), a l...

May 31, 2023 | News

Amplo Biotech Secures Fast Track Funding for Promising Gene Therapy Targeting Collagen Q Deficiency

Under an exclusive licensing agreement, Amplo Biotechnology has gained access to AAV-ColQ data developed by Professor Kinji Ohno's laboratory at&...

May 30, 2023 | News

FivepHusion partners with Treehill Partners and Syneos Health for strategic collaboration

FivepHusion, an advanced clinical-stage biotechnology company, today announced its collaboration with Treehill Partners, a New York-based strategic an...

May 29, 2023 | News

Daewoong Pharmaceutical Reveals Bersiporocin's Antifibrotic Mechanism

Daewoong Pharmaceutical (CEO Lee Chang-jae and Jeon Sengho) announced on the 25th that the molecular mechanism behind safety and efficacy of Bersiporo...

May 26, 2023 | News

Oncodesign and Veritas In Silico Collaborate on mRNA-Targeted Drug Development

The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional pro...

May 25, 2023 | News

SK Bioscience Proposes Vaccine Access Solution at World Economic Forum's Collaborative

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company's CE...

May 24, 2023 | News

Thousand Oaks Biologics and GeneQuantum Healthcare Partner for ADC Drug Development

The over 200 million RMB collaboration will allow GQ to leverage TOBio's expertise in CMC and commercial manufacturing to advance its pharmaceutica...

May 23, 2023 | News

TVM Capital Healthcare Announces Euro 10 Million Investment in DEBx Medical

TVM Capital Healthcare, a global specialist healthcare private equity firm headquartered in Dubai and Singapore, is pleased to announce an i...

May 23, 2023 | News

Boan Biotech's BA1202 Approved for Clinical Trial

Boan Biotech announced today that its BA1202, a CEACAM5 (CEA)/CD3 bispecific antibody, has been approved for a clinical trial by the Center for Drug Evalua...

May 17, 2023 | News

Neutec Group Launches oCelloscope: Automated Microbial Live-Cell Imaging by Biosense Solutions

With +80 US/EU peer reviewed publications, the oCelloScope is a one-of-a-kind workhorse in many microbial applications. In AST,...

May 17, 2023 | News

TVM Capital Healthcare opens office in Riyadh, Saudi Arabia

Establishing this local office comes after TVM Capital Healthcare successfully expanded its portfolio company Cambridge Medical and Rehabilitation Center f...

May 16, 2023 | News

Hummingbird Bioscience to showcase preclinical proof of concept for novel autoimmune disease antibody

HMBD-011 is a potentially first-in-class anti-VH4-34 antibody developed for treatment of VH4-34+ antibody-driven pathogenesis in lupus and cold agglutini...

May 09, 2023 | News

Neuro3 Therapeutics obtains global rights for KCNQ2 activators from Lundbeck

The agreement focuses on activators of KCNQ2, an ion channel that has been clinically validated as a target for the treatment of epilepsy. Clinical findin...

May 09, 2023 | Opinion

Stay Connected